---
title: "Erasca grants new R&D chief Charles Fuchs options for 1,278,520 shares under inducement plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295443047.md"
description: "Erasca granted new R&D President Charles S. Fuchs options for 1,278,520 shares under its inducement plan. The options were granted on August 10, 2026, with an exercise price based on the Nasdaq closing price that day. Vesting begins with 25% on August 10, 2027, followed by the remaining 75% in 36 equal monthly installments."
datetime: "2026-08-10T20:01:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295443047.md)
  - [en](https://longbridge.com/en/news/295443047.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295443047.md)
generator: "portal-rs"
---

# Erasca grants new R&D chief Charles Fuchs options for 1,278,520 shares under inducement plan

-   Erasca set inducement stock-option terms for new R&D president Charles S. Fuchs, covering 1,278,520 shares under its 2026 plan. \* Vesting schedule: 25% on Aug. 10, 2027; remaining 75% in 36 equal monthly installments. \* Options granted Aug. 10, 2026; exercise price set at the Nasdaq closing price of Erasca shares on the grant date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Erasca Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608101601PRIMZONEFULLFEED9807043) on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ERAS.US](https://longbridge.com/en/quote/ERAS.US.md)

## Related News & Research

- [What Erasca Stock's Pipeline Data Update Means For Shareholders](https://longbridge.com/en/news/298679987.md)
- [Erasca to present updated Phase 1 AURORAS-1 monotherapy data for ERAS-0015 at ENA Symposium](https://longbridge.com/en/news/298590990.md)
- [Erasca to present at Morgan Stanley Global Healthcare Conference](https://longbridge.com/en/news/298306474.md)
- [Algert Global LLC Cuts Stake in Erasca, Inc. $ERAS](https://longbridge.com/en/news/297476915.md)
- [Era Graharealty announces extraordinary shareholder meeting plan](https://longbridge.com/en/news/298651467.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**